Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2009
11/18/2009CN101579396A Euphorbia humifusa dispersing tablet and preparation process thereof
11/18/2009CN101579394A Trichosanthes bark dropping pill and preparation method thereof
11/18/2009CN101579393A Traditional Chinese medicine ophthalmic preparation and preparation technology thereof
11/18/2009CN101579391A Traditional Chinese medicine effervescent tablet for preventing and curing cold
11/18/2009CN101579390A Medicinal dripping pill for treating osteoporosis
11/18/2009CN101579385A Medicinal dripping pill for treating anorexia nervosa
11/18/2009CN101579380A Medicinal dripping pill for treating diabetes mellitus
11/18/2009CN101579378A Medicinal dripping pill for treating senile dementia
11/18/2009CN101579370A Stable liquid curbitacin preparation and method for preparing same
11/18/2009CN101579367A Medicinal dripping pill for treating rickets
11/18/2009CN101579364A Pharmaceutical composition and preparation method thereof
11/18/2009CN101579363A Traditional Chinese medicine ophthalmic preparation and preparation method thereof
11/18/2009CN101579359A Compound cod-liver oil nasal drops and preparation method
11/18/2009CN101579358A Ready-to-use traditional Chinese medicine ophthalmic gel
11/18/2009CN101579357A Ready-to-use fel ursi ophthalmic gel
11/18/2009CN101579356A Deproteinated calf blood ingredient brain targeting nanosphere and preparation method thereof
11/18/2009CN101579350A Phosphatide composite, preparation method and application thereof
11/18/2009CN101579347A Breast perfusion preparation for treating mammitis of milk cow in lactation period and preparation method thereof
11/18/2009CN101579337A Clopidogrel composition and preparation method thereof
11/18/2009CN101579336A Aztreonam for injection and production method thereof
11/18/2009CN101579335A New formulation of medicament, preparation method and application method
11/18/2009CN101579333A Medicament for treating soft tissue injury and arthritis and gel preparation method
11/18/2009CN101579329A Bevantolol hydrochloride sustained release preparation
11/18/2009CN101579327A Azithromycin enteric capsule and preparation method thereof
11/18/2009CN101579326A Pulullan polysaccharide empty hard capsule and preparation method thereof
11/18/2009CN101579325A Metformin hydrochloride controlled-release tablet and preparation method thereof
11/18/2009CN101579324A Method for preparing omeprazole enteric fast-release tablet
11/18/2009CN101579323A Butylphenyl phthaleine sustained release tablet and preparation method thereof
11/18/2009CN101579322A Method for preparing dimethyldiguanide tablet
11/18/2009CN101579321A Preparation process for glimepiride tablet
11/18/2009CN101579320A Sildenafil citrate sublingual tablet and preparation method thereof
11/18/2009CN101579319A Medical prescription of catalpol freezing-drying powder for injection and preparation method
11/18/2009CN101579317A Intragastric floating slowly releasing micropill and preparation method thereof
11/18/2009CN101579316A Preparation method of superparamagnetic cyclodextrin composite particles
11/18/2009CN101579315A Immunoliposome based on endostatin gene, preparation method and application thereof
11/18/2009CN101579314A Anti-cancer drug sustained-release preparation of organic-inorganic complex liposome and preparation method thereof
11/18/2009CN101579313A Cefalexin liposome and medicinal composition thereof
11/18/2009CN101579312A Teniposide liposome and preparation method thereof
11/18/2009CN101579310A Decataxel self-microemulsifying composition and preparation method thereof
11/18/2009CN101579309A Anti-parasitic ivermectin transdermal solution used for livestock and preparation method thereof
11/18/2009CN101579306A Ciclopirox olamine pessary and preparation method thereof
11/18/2009CN101579305A Ready-to-use puerarin ophthalmic gel
11/18/2009CN101579291A Resveratrol phospholipid composite nano-emulsion and preparation method and application thereof
11/18/2009CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/18/2009CN100560636C Preparing process of chitosan grafted nano polylactic acid particle
11/18/2009CN100560606C Mussel glucan and its preparation method and application
11/18/2009CN100560489C Preparation method and application of macropore-mesoporous silicon dioxide hollow micro-sphere
11/18/2009CN100560137C Bacteria nano magnetosome loaded with primary amine medicine and preparation method thereof
11/18/2009CN100560136C Ferrite/bacille calmette-guerin vaccine/temperature sensing gel integration material and preparation thereof
11/18/2009CN100560135C Application of gellan gum in slow release preparation
11/18/2009CN100560134C Elemene inclusion complex, preparation and preparation process thereof
11/18/2009CN100560133C Nanometer magnetic polylactic acid-phenyl arsine glycollate microballoon and its pharmaceutical use
11/18/2009CN100560131C Antibody targeting compounds
11/18/2009CN100560127C Effervescent tablet of human interferon-alpha-2b and its preparation process
11/18/2009CN100560077C Pharmaceutical composition and its preparation method and uses
11/18/2009CN100560072C Hydrochloric acid olprinone injection and method for preparing the same
11/18/2009CN100560069C Mitiglinide calcium formulation and its detection method
11/18/2009CN100560068C Levogyration sulpiride injection preparation method
11/18/2009CN100560067C Hydrochloric acid dronedarone medicinal compositions for oral use and method for preparing the same
11/18/2009CN100560061C Lornoxicam freeze-dried injection and preparation method thereof
11/18/2009CN100560059C Co-grinding process for the preparation of a ternary composition
11/18/2009CN100560058C Fast-effective oral analgesic
11/18/2009CN100560055C Ophthalmic gel and its preparation method
11/17/2009US7619068 Antiovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo; detecting Ovr110 overexpression
11/17/2009US7619066 IL-1ra variants
11/17/2009US7619006 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity
11/17/2009US7619001 Utilization of dialkylfumarates
11/17/2009US7618657 For increasing hemoglobin expression level, reactivating fetal or adult hemoglobin, inducing gamma -globin, stimulating cell differentiation, inhibiting malignant cell proliferation, or treating a hemoglobinopathy or a malignant disease
11/17/2009US7618651 gel comprising glycerol formal solvent, hydroxypropyl methylcellulose and a dissolved antibacterial agent Tobramycin, antifungal agent Terbinafine , and a steroid Betamethasone; controlled- or sustained-release; treating microbial infection of the skin, ear, or eye, especially for veterinary medicine
11/17/2009US7618649 For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618637 Therapeutic mixture comprising chaperone protein for use in treatment and prevention of autoimmune, infectious and allergic disorders
11/17/2009US7618634 Neurotoxic oligomers
11/17/2009US7618631 Treating ErbB2-expressing cancer in a human by administering an antibody which binds ErbB2 and comprises variable light (VL) domain and variable heavy (VH) domain amino acid sequences and an antiestrogen; antitumor and antimetastasis agents; side effect reduction
11/17/2009US7618619 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
11/17/2009CA2554346C Parenteral formulations comprising a beta-cyclodextrin and a preservative
11/17/2009CA2379365C Transnasal anticonvulsive compositions and modulated process
11/17/2009CA2376850C Topical formulations comprising skin penetration agents and the use thereof
11/17/2009CA2351814C Taste masked pharmaceutical particles
11/17/2009CA2341429C Treatment of mucus hypersecretion
11/17/2009CA2338457C Preparation of aqueous clear solution dosage forms with bile acids
11/17/2009CA2304973C Stabilized preparations for use in nebulizers
11/17/2009CA2288694C Active vitamin d3 emulsion lotion
11/17/2009CA2265952C Injection formulations of avermectins and milbemycins
11/17/2009CA2258483C Biocompatible devices with foam scaffolds
11/17/2009CA2208246C Formulations and methods for reducing skin irritation
11/17/2009CA2157577C Growth differentiation factor-8
11/16/2009CA2666036A1 Novel compositions and methods for treating hyperproliferative diseases
11/12/2009WO2009137611A2 Treatment of pulmonary fungal infection with voriconazole via inhalation
11/12/2009WO2009137080A1 Compositions of gnrh related compounds and processes of preparation
11/12/2009WO2009137078A1 Compositions of peptides and processes of preparation thereof
11/12/2009WO2009136572A1 Polymer conjugate of folic acid or folic acid derivative
11/12/2009WO2009136352A1 Anti-angiogenic compounds
11/12/2009WO2009136056A2 High-fluidity and non-caking pulverulent crystalline maltitol composition
11/12/2009WO2009135957A1 Tooth movement activating compound
11/12/2009WO2009135888A2 Complex
11/12/2009WO2009135852A2 Encapsulation of biologically active agents
11/12/2009WO2009115967A3 Method for the synthesis of hollow spheres
11/12/2009WO2009111852A3 Solid lipid nanoparticles containing retinoids
11/12/2009WO2009108828A3 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 1712